《Chinese Journal of Rehabilitation Theory and Practice》 ›› 2019, Vol. 25 ›› Issue (9): 1038-1042.doi: 10.3969/j.issn.1006-9771.2019.09.008
Previous Articles Next Articles
LIU Kai-xin, GONG Chao-yang, XIANG Gao, ZHANG Hai-hong
Received:2019-02-17
Revised:2019-04-22
Published:2019-09-25
Online:2019-09-25
Contact:
ZHANG Hai-hong, E-mail: zhanghaihong1968@sina.com
E-mail:zhanghaihong1968@sina.com
Supported by:CLC Number:
LIU Kai-xin, GONG Chao-yang, XIANG Gao, ZHANG Hai-hong. Advance of Botulinum Toxin A in Neurological Disorders (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2019, 25(9): 1038-1042.
| 1 SmithT J, HillK K, RaphaelB H. Historical and current perspectives on Clostridium Botulinum diversity [J]. Res Microbiol, 2015, 166(4): 290-302. 2 RossettoO, PirazziniM, MontecuccoC. Botulinum neurotoxins: genetic, structural and mechanistic insights [J]. Nat Rev Microbiol, 2014, 12(8): 535-549. 3 MontecuccoC, RasottoM B. On Botulinum neurotoxin variability [J]. MBio, 2015, 6(1): e02131-14. 4 Carrillo-MarquezM A. Botulism [J]. Pediatr Rev, 2016, 37(5): 183-192. 5 CarruthersJ, BurgessC, DayD, et al. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices [J]. Dermatol Surg, 2016, 42(5): 586-597. 6 HallettM, AlbaneseA, DresslerD, et al. Evidence-based review and assessment of Botulinum neurotoxin for the treatment of movement disorders [J]. Toxicon , 2013, 67: 94-114. 7 DresslerD. Clinical applications of Botulinum toxin [J]. Curr Opin Microbiol, 2012, 15(3): 325-336. 8 MasuyerG, ChaddockJ A, FosterK A, et al. Engineered Botulinum neurotoxins as new therapeutics [J]. Annu Rev Pharmacol Toxicol, 2014, 54: 27-51. 9 MasuyerG, DaviesJ R, MooreK, et al. Structural analysis of Clostridium Botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors [J]. Sci Rep, 2015, 5: 13397. 10 HuL, ZouY, ChangS J, et al. Effects of Botulinum toxin on improving facial surgical scars: a prospective, split-scar, double-blind, randomized controlled trial [J]. Plast Reconstr Surg, 2018, 141(3): 646-650. 11 ChancellorM B, FowlerC J, ApostolidisA, et al. Drug insight: biological effects of Botulinum toxin A in the lower urinary tract [J]. Nat Clin Pract Urol, 2008, 5(6): 319-328. 12 EsquenaziA, AlbaneseA, ChancellorM B, et al. Evidence-based review and assessment of Botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome [J]. Toxicon, 2013, 67: 115-128. 13 TangQ, ChenC, WangX, et al. Botulinum toxin A improves adipose tissue engraftment by promoting cell proliferation, adipogenesis and angiogenesis [J]. Int J Mol Med, 2017, 40(3): 713-720. 14 ChenF, KuziemkoG M, StevensR C. Biophysical characterization of the stability of the 150-kilodalton Botulinum toxin, the nontoxic component, and the 900-kilodalton Botulinum toxin complex species [J]. Infect Immun, 1998, 66(6): 2420-2425. 15 RummelA. The long journey of Botulinum neurotoxins into the synapse [J]. Toxicon, 2015, 107(Pt A): 9-24. 16 FrevertJ. Content of Botulinum neurotoxin in Botox(R)/Vistabel(R), Dysport(R)/Azzalure(R), and Xeomin(R)/Bocouture(R) [J]. Drugs R D, 2010, 10(2): 67-73. 17 杨明娜,苏俊辉,张小龙,等. 原发性与面瘫后面肌痉挛患者面部异常运动A型肉毒毒素的治疗效果对比研究[J]. 卒中与神经疾病, 2019, 26(01): 77-81. 18 ComellaC L, PullmanS L. Botulinum toxins in neurological disease [J]. Muscle Nerve, 2004, 29(5): 628-644. 19 Ramirez-CastanedaJ, JankovicJ. Long-term efficacy, safety, and side effect profile of Botulinum toxin in dystonia: a 20-year follow-up [J]. Toxicon , 2014, 90: 344-348. 20 SimpsonD M, HallettM, AshmanE J, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology [J]. Neurology, 2016, 86(19): 1818-1826. 21 TsuiJ K, EisenA, MakE, et al. A pilot study on the use of Botulinum toxin in spasmodic torticollis [J]. Can J Neurol Sci, 1985, 12(4): 314-316. 22 WheelerA, SmithH S. Botulinum toxins: mechanisms of action, antinociception and clinical applications [J]. Toxicology, 2013, 306: 124-146. 23 曹腾腾,叶蕾,郑海霞. 扳机点注射A型肉毒杆菌毒素联合活血通络胶囊治疗原发性三叉神经痛疗效及对血浆CGRP、SP、IL-6、IL-1β水平的影响[J]. 现代中西医结合杂志, 2018, 27(30): 3328-3331, 3335. 24 ArgoffC E. A focused review on the use of Botulinum toxins for neuropathic pain [J]. Clin J Pain, 2002, 18(6 Suppl): S177-S181. 25 BuonocoreM, DemartiniL, MandriniS, et al. Effect of Botulinum toxin on disabling neuropathic pain: a case presentation suggesting a new therapeutic strategy [J]. PM R, 2017, 9(2): 200-203. 26 MorraM E, ElgebalyA, ElmaraezyA, et al. Therapeutic efficacy and safety of Botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials [J]. J Headache Pain, 2016, 17(1): 63. 27 杨琼,李剑,张洁,等. A型肉毒素治疗原发性头痛研究进展[J]. 中国神经免疫学和神经病学杂志, 2018, 25(6): 439-442. 28 ChenS. Clinical uses of Botulinum neurotoxins: current indications, limitations and future developments [J]. Toxins, 2012, 4(10): 913-939. 29 LuvisettoS, GazeraniP, CianchettiC, et al. Botulinum toxin type A as a therapeutic agent against headache and related disorders [J]. Toxins, 2015, 7(9): 3818-3844. 30 CutrerF M. Pathophysiology of migraine [J]. Semin Neurol, 2010, 30(2): 120-130. 31 OlesenJ, BursteinR, AshinaM, et al. Origin of pain in migraine: evidence for peripheral sensitisation [J]. Lancet Neurol, 2009, 8(7): 679-690. 32 ShevelE. The extracranial vascular theory of migraine－a great story confirmed by the facts [J]. Headache, 2011, 51(3): 409-417. 33 JacksonJ L, KuriyamaA, HayashinoY. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis [J]. JAMA, 2012, 307(16): 1736-1745. 34 刘景隆,郭天龙,吕英,等. A型肉毒素局部注射对脑卒中后痉挛性上肢功能障碍的影响[J]. 中国康复理论与实践, 2012, 18(7): 640-642. 35 DresslerD, SaberiF A, KolleweK, et al. Safety aspects of incobotulinumtoxinA high-dose therapy [J]. J Neural Transm (Vienna), 2015, 122(2): 327-333. 36 SantamatoA, MicelloM F, RanieriM, et al. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke [J]. J Neurol Sci, 2015, 350(1-2): 1-6. 37 KutschenkoA, ManigA, ReinertM C, et al. In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA [J]. Neurosci Lett, 2016, 627: 216-221. 38 GraciesJ M, LugassyM, WeiszD J, et al. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study [J]. Arch Phys Med Rehabil, 2009, 90(1): 9-16, e2. 39 AlbaneseA, LalliS. Is this dystonia? [J]. Mov Disord, 2009, 24(12): 1725-1731. 40 AlbaneseA, LalliS. Update on dystonia [J]. Curr Opin Neurol, 2012, 25(4): 483-490. 41 刘建军,纪树荣. A型肉毒毒素治疗痉挛的临床应用[J]. 中国康复理论与实践, 2001, 7(3): 39-40. 42 GraciesJ M. Physiological effects of botulinum toxin in spasticity [J]. Mov Disord, 2004, 19(Suppl 8): S120-S128. 43 GiladiN. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site [J]. J Neurol Sci, 1997, 152(2): 132-135. 44 HallettM. How does botulinum toxin work? [J]. Ann Neurol, 2000, 48(1): 7-8. 45 RosalesR L, DresslerD. On muscle spindles, dystonia and botulinum toxin [J]. Eur J Neurol, 2010, 17(Suppl 1): 71-80. 46 CaleoM, SchiavoG. Central effects of tetanus and botulinum neurotoxins [J]. Toxicon, 2009, 54(5): 593-599. 47 HubbardK, BeskeP, LymanM, et al. Functional evaluation of biological neurotoxins in networked cultures of stem cell-derived central nervous system neurons [J]. J Vis Exp, 2015. doi: 10.3791/52361. 48 BentivoglioA R, del GrandeA, PetraccaM, et al. Clinical differences between Botulinum neurotoxin type A and B [J]. Toxicon, 2015, 107(Pt A): 77-84. 49 KarpB I. Botulinum toxin treatment of occupational and focal hand dystonia [J]. Mov Disord, 2004, 19(Suppl 8): S116-S119. 50 SchneiderS A, EdwardsM J, CordivariC, et al. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease [J]. Mov Disord, 2006, 21(10): 1722-1724. 51 BentivoglioA R, FasanoA, IalongoT, et al. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm [J]. Eur J Neurol, 2009, 16(3): 392-398. 52 LotiaM, JankovicJ. Botulinum toxin for the treatment of tremor and tics [J]. Semin Neurol, 2016, 36(1): 54-63. 53 SimoensS, LaekemanG. Pharmacotherapy of allergic rhinitis: a pharmaco-economic approach [J]. Allergy, 2009, 64(1): 85-95. 54 OzcanC, IsmiO. Botulinum toxin for rhinitis [J]. Curr Allergy Asthma Rep, 2016, 16(8): 58. 55 钟海虎. 逼尿肌内注射A型肉毒毒素对特发性膀胱过度活动症和神经源性膀胱过度活动症疗效的比较[J]. 中国医学创新, 2018, 15(16): 1-5. 56 SchurchB, StohrerM, KramerG, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results [J]. J Urol, 2000, 164(3 Pt 1): 692-697. 57 FowlerC J, GriffithsD, de GroatW C. The neural control of micturition [J]. Nat Rev Neurosci, 2008, 9(6): 453-466. 58 ApostolidisA, PopatR, YiangouY, et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity [J]. J Urol, 2005, 174(3): 977-983. 59 DugganM J, QuinnC P, ChaddockJ A, et al. Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin [J]. J Biol Chem, 2002, 277(38): 34846-34852. 60 RappD E, TurkK W, BalesG T, et al. Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder [J]. J Urol, 2006, 175(3 Pt 1): 1138-1142. 61 KheraM, SomogyiG T, KissS, et al. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury [J]. Neurochem Int, 2004, 45(7): 987-993. 62 ChuangY C, YoshimuraN, HuangC C, et al. Intraprostatic Botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat [J]. J Urol, 2008, 180(2): 742-748. 63 SmithC P, RadziszewskiP, BorkowskiA, et al. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis [J]. Urology, 2004, 64(5): 871-875. 64 WangJ, WangQ, WuQ, et al. Intravesical Botulinum toxin A injections for bladder pain syndrome/interstitial cystitis: a systematic review and meta-analysis of controlled studies [J]. Med Sci Monit, 2016, 22: 3257-3267. 65 LiuB L, YangF, ZhanH L, et al. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome [J]. Urol Int, 2014, 92(2): 202-208. 66 PapagiannopoulouD, VardouliL, DimitriadisF, et al. Retrograde transport of radiolabelled Botulinum neurotoxin type A to the CNS after intradetrusor injection in rats [J]. BJU Int, 2016, 117(4): 697-704. |
| [1] | SHAO Weiting, LEI Jianghua. Effect of response interruption and redirection as a behavioral intervention on vocal stereotypy in children with autism spectrum disorder: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 10-20. |
| [2] | WANG Hangyu, GE Keke, FAN Yonghong, DU Lilu, ZOU Min, FENG Lei. Effect of active music therapy on cognitive function for older adults with cognitive impairment: a systematic review based on ICD-11 and ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 36-43. |
| [3] | WEN Jianing, JIN Qiuyan, ZHANG Qi, LI Jie, SI Qi. Effect of cognitively engaging physical activity on developing executive function of children and adolescents: a systematic review based on ICF [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 44-53. |
| [4] | GE Keke, FAN Yonghong, WANG Hangyu, DU Lilu, LI Changjiang, ZOU Min. Health benefit of mindfulness intervention for older adults with insomnia disorders: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2024, 30(1): 54-60. |
| [5] | ZHANG Jingya, ZOU Min, SUN Hongwei, SUN Changlong, ZHU Juntong. Effect of psychological intervention on anxiety or depression in children and adolescents with hearing impairment: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1004-1011. |
| [6] | WANG Junyu, YANG Yong, YUAN Xun, XIE Ting, ZHUANG Jie. Effect of high-intensity interval training on executive function for healthy children and adolescents: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1012-1020. |
| [7] | WEI Xiaowei, YANG Jian, WEI Chunyan. Psychological and behavioral benefits of adapted yoga exercise for children with autism spectrum disorder in special education schools: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1021-1028. |
| [8] | YANG Yaru, YANG Jian. School-based physical activity-related health services and their health benefits within the World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1040-1047. |
| [9] | WANG He, HAN Liang, KAN Mengfan, YU Shaohong. Efficacy of electrical stimulation on shoulder-hand syndrome after stroke: a systematic review and meta-analysis [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1048-1056. |
| [10] | SHI Jiawei, LI Lingyu, YANG Haojie, WANG Qinlu, ZOU Haiou. Effect of preoperative prerehabilitation training on total knee arthroplasty: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(9): 1057-1064. |
| [11] | JIANG Changhao, HUANG Chen, GAO Xiaoyan, DAI Yuanfu, ZHAO Guoming. Effect of neurofeedback training on cognitive function in the elderly: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 903-909. |
| [12] | WEI Xiaowei, YANG Jian, WEI Chunyan, HE Qiling. Adapted physical education programs for psychomotor development in school settings for children with intellectual and developmental disabilities: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(8): 910-918. |
| [13] | ZHANG Yuan, YANG Jian. School health services and effectiveness based on World Health Organization health-promoting school framework: a scoping review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 791-799. |
| [14] | WANG Shaopu, CHEN Gang. Psychological-behavioral health services and its outcome based on World Health Organization health-promoting school framework: a systematic review of systematic reviews [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(7): 800-807. |
| [15] | JIANG Changhao, GAO Xiaoyan. Effect of acute physical activity on cognitive function in children: a systematic review [J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2023, 29(6): 667-672. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
||
